Text Size

Efficacy and Safety of the Hcoil Deep TMS for the Treatment of Cannabis Addiction

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2007 by Shalvata Mental Health Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Shalvata Mental Health Center
ClinicalTrials.gov Identifier:
NCT00543036
First received: October 11, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
  Purpose

Evaluation of efficacy and safety of H-coil deep transcranial magnetic stimulation 9 week treatment trial for cannabis addiction as assessed by measures of drug intake and craving.


Condition Intervention Phase
Marijuana Abuse
 Device: H-Coil deep TMS
 Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment

Resource links provided by NLM:

MedlinePlus related topics: Marijuana
U.S. FDA Resources

Further study details as provided by Shalvata Mental Health Center:

  Eligibility

Ages Eligible for Study:   21 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male and Female, aged 21-70 years, who meet DSM-IV TR diagnostic criteria for cannabis abuse and are motivated to quit cannabis use as assessed in the screening visit and gave their written informed consent to participate in the study.

Exclusion Criteria:

  • History of a primary major psychiatric other then cannabis abuse, or cognitive disorder according to DSM-IV TR criteria.
  • Hamilton depression scale rated 25 and above (moderate to severe depression)
  • Current alcohol or other substance abuse or dependence
  • Alcohol or other substance abuse or dependence during the last 12 months before recruitment.
  • History of or evidence of significant brain malformation,neoplasm, head injury, cerebral vascular events,neurodegenerative disorder or brain surgery.
  • Severe somatic co-morbidity
  • History of seizures Cardiac pace maker or other electronic implants Pregnancy and lactation
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00543036

Contacts
Contact: Ziv Carmel, M.D. +972-9-7478570 zivca@clalit.org.il

Locations
Israel
Shalvata Mental Health Center Recruiting
Hod-HaSharon, Israel, 45100
Contact: Ziv Carmel, M.D     +972-9-7478570     zivca@clalit.org.il    
Principal Investigator: Ziv Carmel, M.D            
Sponsors and Collaborators
Shalvata Mental Health Center
Investigators
Principal Investigator: Ziv Carmel, M.D Shalvata MHC affiliated to Tel-Aviv universtiy, Sackler school of medicine
Principal Investigator: Abraham Zangen, Ph.D. Weizmann Institute, Rehovot, Israel
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00543036     History of Changes
Other Study ID Numbers: SH 30107
Study First Received: October 11, 2007
Last Updated: October 11, 2007
Health Authority: Israel: Ministry of Health

Keywords provided by Shalvata Mental Health Center:
Cannabis
Addiction
Craving
TMS

Additional relevant MeSH terms:
Marijuana Abuse
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 21, 2013